OBJECTIVE: To establish drug utilization review(DUR) procedure suitable for patients with malignant lymphoma(ML) in our hospital.
目的:探讨建立适合本医院恶性淋巴瘤(ML)患者的药物利用评价程序。
OBJECTIVE: To establish drug utilization review(DUR) procedure suitable for patients with malignant lymphoma(ML) in our hospital.
目的:探讨建立适合本医院恶性淋巴瘤(ML)患者的药物利用评价程序。
应用推荐